BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26350179)

  • 1. Loss of heterozygosity in thyroid hormone receptor beta in invasive breast cancer.
    Ling Y; Li Q; Yang H; Wang Y; Tang F; Kang H; Wang Y
    Tumori; 2015; 101(5):572-7. PubMed ID: 26350179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
    Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
    Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Loss of heterozygosity on chromosome 3p in breast cancer and precancerous lesion].
    Tang XL; Yao GY; Chen LR; Yang ZR; Li SL
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1314-7. PubMed ID: 17217815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at BRCA1 locus is significantly associated with aggressiveness and poor prognosis in breast cancer.
    Okada S; Tokunaga E; Kitao H; Akiyoshi S; Yamashita N; Saeki H; Oki E; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 May; 19(5):1499-507. PubMed ID: 22179631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer.
    Silva JM; Gonzalez R; Provencio M; Dominguez G; Garcia JM; Gallego I; Palacios J; España P; Bonilla F
    Breast Cancer Res Treat; 1999 Jan; 53(1):9-17. PubMed ID: 10206068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant allelic loss of ANX7region (10q21) in hormone receptor negative breast carcinomas.
    Leighton X; Srikantan V; Pollard HB; Sukumar S; Srivastava M
    Cancer Lett; 2004 Jul; 210(2):239-44. PubMed ID: 15183540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability and loss of heterozygosity in primary breast tumours.
    Sourvinos G; Kiaris H; Tsikkinis A; Vassilaros S; Spandidos DA
    Tumour Biol; 1997; 18(3):157-66. PubMed ID: 9143412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer.
    Qiu H; Lotan R; Lippman SM; Xu XC
    Genes Chromosomes Cancer; 2000 Jun; 28(2):196-202. PubMed ID: 10825004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
    Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
    Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
    Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
    J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
    Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer.
    Tokunaga E; Yamashita N; Kitao H; Tanaka K; Taketani K; Inoue Y; Saeki H; Oki E; Oda Y; Maehara Y
    Breast; 2016 Feb; 25():62-8. PubMed ID: 26577950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
    Tokunaga E; Okada S; Yamashita N; Akiyoshi S; Kitao H; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2012 Apr; 19(2):161-9. PubMed ID: 21063923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype.
    Roncuzzi L; Brognara I; Cocchi S; Zoli W; Gasperi-Campani A
    Cancer Genet Cytogenet; 2002 Jun; 135(2):173-6. PubMed ID: 12127402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content.
    Huiping C; Eiriksdottir G; Sigurdsson A; Sigurgeirsdottir JR; Barkardottir RB; Egilsson V; Ingvarsson S
    Anticancer Res; 1998; 18(2A):1031-6. PubMed ID: 9615760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer.
    Caldés T; Perez-Segura P; Tosar A; de La Hoya M; Diaz-Rubio E
    Teratog Carcinog Mutagen; 2000; 20(5):283-91. PubMed ID: 10992275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma.
    Tokunaga E; Oki E; Kimura Y; Yamanaka T; Egashira A; Nishida K; Koga T; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2007 Mar; 101(3):249-57. PubMed ID: 17006756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.